https://www.illumina.com/products/by-type/clinical-research-products/trusight-cancer-hereditary.html
TruSight Hereditary Cancer Panel | Target 113 cancer-associated genes
Targeted sequencing panel that assesses germline mutations across 113 genes and 125 SNPs associated with genetic cancer risk predisposition.
hereditary cancertrusightpaneltarget113
https://www.illumina.com/company/news-center/feature-articles/tso-500-selected-to-power-liquid-biospy-studies.html
TruSight Oncology 500 selected to power liquid biopsy studies
Liquid biopsy is still in its infancy and requires additional validation to more fully demonstrate clinical utility. Illumina recently entered into a 5-year...
liquid biopsytrusightoncology500selected
https://www.upguard.com/security-report/trusight
TruSight Security Rating, Vendor Risk Report, and Data Breaches | UpGuard
Compare TruSight's security performance with other companies. Learn about data breaches, cyber attacks, and security incidents involving TruSight.
security ratingvendor riskdata breachestrusightreport
https://trusightllc.com/
Deal Sourcing Subscription for PE Firms & Family Offices | TruSight
TruSight delivers curated deal flow from 13,000+ long-tail intermediaries to PE firms, family offices, and search funds. See how your criteria benchmarks...
for pe firmsdeal sourcingfamily officessubscriptiontrusight
https://www.illumina.com/products/by-type/ivd-products/trusight-oncology-comprehensive-us.html
TruSight Oncology Comprehensive | Order now | CE-marked IVD CGP
The first US FDA-approved distributable comprehensive genomic profiling (CGP) IVD with pan-cancer companion diagnostic (CDx) claims.
order nowce markedtrusightoncologycomprehensive
https://www.illumina.com/products/by-type/clinical-research-products/trusight-oncology-500.html
TruSight Oncology 500 v2 | Enable CGP utilizing DNA and RNA from FFPE tissue
Enable CGP with a large pan-cancer panel covering all main variant classes plus key biomarkers (TMB, MSI, and HRD) from FFPE tissue.
dna and rna
https://www.illumina.com/products/by-brand/trusight-oncology/tso-500-portfolio.html?scid=2021-269ECL4849
TruSight Oncology 500 Product Line
The TruSight Oncology 500 product line enables comprehensive genomic profiling from both blood and tissue samples for clinical research applications.
trusightoncology500productline
https://trusight.tech/
Trusight Studios | Full-Stack Development, AI/ML & Custom Software
Trusight Studios builds production-grade software systems. Full-stack development, AI/ML integration, IoT, cloud infrastructure, and custom software solutions...
full stack developmentai mltrusightstudioscustom
https://investingnews.com/illumina-secures-cms-reimbursement-for-trusight-oncology-comprehensive-expanding-access-to-precision-oncology/
Illumina secures CMS reimbursement for TruSight Oncology Comprehensive, expanding access to...
Jan 20, 2026 - The FDA-approved comprehensive genomic profiling test will be reimbursed at a rate of $2,989.55 per test, helping to advance adoption in the US healthcare...
expanding accessilluminasecurescmsreimbursement